Burkitt lymphoma is a highly curable disorder when treated with modern intensive chemotherapy regimens. The majority of adult patients with Burkitt lymphoma in the United States are over age 40 years.
Aggressive malignancies respond best to aggressive dose-intense therapies; oncologists hold this truth to be self-evident. However, in adults with the extremely aggressive Burkitt's lymphoma, a ...
Burkitt’s lymphoma owes its name to the Irish surgeon Denis P. Burkitt, who in 1958 described 38 Ugandan children with rapidly enlarging facial tumors that were uniformly fatal. 7 He postulated that ...
Burkitt’s leukemia, or Burkitt’s lymphoma, occurs when tumor cells develop in the bone marrow and bloodstream. Burkitt’s lymphoma is a rare type of non-Hodgkin lymphoma. Lymphoma is a blood cancer ...
Miriam Sevy was a force of nature. That is how Dr. Steve Kussick, president of the board for the all-volunteer, Seattle-based Burkitt’s Lymphoma Fund for Africa, remembers the nonprofit’s founder. A ...
There’s more than one way to tell the story of a pioneering Irish medic, and for his chronicling of the life and times of Co Fermanagh cancer researcher Denis Burkitt, film-maker Éanna Mac Cana has ...
The distinction between Burkitt's lymphoma and diffuse large-B-cell lymphoma is crucial because these two types of lymphoma require different treatments. We examined whether gene-expression profiling ...
Burkitt lymphoma is an extremely fast growing form of non-Hodgkin’s lymphoma that originates from a subgroup of white blood cells called B lymphocytes of the immune system. Now, researchers at the Max ...
Burkitt lymphoma is a form of non-Hodgkin's lymphoma in which cancer starts in immune cells called B-cells. Recognized as a fast growing human tumor, Burkitt lymphoma is associated with impaired ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results